235 related articles for article (PubMed ID: 24081576)
1. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.
Fozza C; Pardini S; Marras T; Longu F; Isoni A; Contini S; Longinotti M
Ann Hematol; 2014 May; 93(5):899-900. PubMed ID: 24081576
[No Abstract] [Full Text] [Related]
2. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.
Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI
Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887
[No Abstract] [Full Text] [Related]
3. Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
Baldini S; Rigacci L; Carrai V; Fjerza R; Alterini R; Bosi A
Platelets; 2013; 24(3):242-3. PubMed ID: 22646237
[No Abstract] [Full Text] [Related]
4. Emperipolesis in a patient receiving romiplostim.
Cooper N; Bain BJ
Am J Hematol; 2016 Jan; 91(1):166. PubMed ID: 26407183
[No Abstract] [Full Text] [Related]
5. Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy.
Rodríguez-Lobato LG; Martinez-Cibrian N; Fernández-Avilés F; Gaya A; Pineda-Losada E; Esteve J
Ann Hematol; 2016 Mar; 95(4):665-6. PubMed ID: 26787417
[No Abstract] [Full Text] [Related]
6. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim.
Al-Samkari H; Van Cott EM; Kuter DJ
Ann Hematol; 2019 Mar; 98(3):581-588. PubMed ID: 30446804
[TBL] [Abstract][Full Text] [Related]
8. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
Tarantino MD; Bussel JB; Blanchette VS; Despotovic J; Bennett C; Raj A; Williams B; Beam D; Morales J; Rose MJ; Carpenter N; Nie K; Eisen M
Lancet; 2016 Jul; 388(10039):45-54. PubMed ID: 27103127
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
Meletis J; Katsandris A; Raptis SD; Mantzourani M
Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
[TBL] [Abstract][Full Text] [Related]
10. Remissions after long-term use of romiplostim for immune thrombocytopenia.
Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ
Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382
[No Abstract] [Full Text] [Related]
11. Treatment of chronic immune thrombocytopenia in children with romiplostim.
Chaturvedi S; McCrae KR
Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125
[No Abstract] [Full Text] [Related]
12. [Successful management of primary immune thrombocytopenia with romiplostim during open heart surgery in a hemodialysis patient].
Nishikii H; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2019; 60(1):28-32. PubMed ID: 30726820
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
[No Abstract] [Full Text] [Related]
14. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim.
Beck JC; Burke MJ; Tolar J
Pediatr Blood Cancer; 2010 Mar; 54(3):490-1. PubMed ID: 19908296
[No Abstract] [Full Text] [Related]
15. [Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].
Riu Viladoms G; Creus Baró N; Estefanell Tejero A; Ribas Sala J
Farm Hosp; 2012; 36(5):434-7. PubMed ID: 22871365
[No Abstract] [Full Text] [Related]
16. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
[No Abstract] [Full Text] [Related]
17. Romiplostim or standard of care in patients with immune thrombocytopenia.
Kuter DJ; Rummel M; Boccia R; Macik BG; Pabinger I; Selleslag D; Rodeghiero F; Chong BH; Wang X; Berger DP
N Engl J Med; 2010 Nov; 363(20):1889-99. PubMed ID: 21067381
[TBL] [Abstract][Full Text] [Related]
18. Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period.
Ramakrishna R; Rehman A; Ramakrishna S; Alexander W; Yeo WW
Intern Med J; 2015 Jul; 45(7):718-24. PubMed ID: 25904300
[TBL] [Abstract][Full Text] [Related]
19. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
20. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.
Doobaree IU; Newland A; McDonald V; Nandigam R; Mensah L; Leroy S; Seesaghur A; Patel H; Wetten S; Provan D
Eur J Haematol; 2019 May; 102(5):416-423. PubMed ID: 30758874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
